Takeda Termed Unlikely White Knight For Genzyme Of U.S.
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical has been reported interested in bidding for Genzyme, a U.S.-based biotech, but sources say an offer is unlikely